Quercetin TNF-alfa'nın Epo üzerindeki baskısını engelliyor


Creative Commons License

Özkurt M., Özyurt R., Karadağ A., Erkasap N.

Europhysiology 2018, London, İngiltere, 14 - 16 Eylül 2018, ss.418

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: London
  • Basıldığı Ülke: İngiltere
  • Sayfa Sayıları: ss.418
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

In-vitro studies have shown that TNF-alpha significantly lower

the Epo synthesis in a dose dependent manner in HEPG2 cells

(1). Quercetin is a flavanoid found in many fruits and vegetables

such as oranges, grapefruits and onions which has

been shown to have anti-oxidant and anti-inflammatory cell

protective effect. Novel studies has shown that Quercetin

increases the amount of Epo in-vitro (2). We aimed to try to

remove the inhibition of TNF-alpha on Epo in with quercetin in

HEPG2 cells.

After detecting the non-toxic doses of TNF-alpha and Quercetin

with MTT, we seeded 5*105 HEPG2 cells in 6 well plates.

Each 6 well plates were a group and the groups were; no treatment

group (control), 10 ng/ml TNF-alpha treated group (T),

10μM/ml Quercetin treated group (Q), TNF-alpha and Quercetin

(T+Q) together treated group. After 24 hour of incubation

we collected the cells and isolated total RNA, synthesied

cDNA and performed Q-PCR for Epo. Data were analyzed by

Kruskal-Wallis test and Dunn’s test for post-hoc.

TNF-alpha significantly decreased (p<0,05) the Epo mRNA

amount according to control group. In Quercetin alone

treated group and the combination treatment group,

Epo mRNA amount were same about the control group.

More detailed studies has to be done but this initial study

shows that Quercetin may prevent the Epo suprression by

TNF-alpha. We will try to explain the mechanism to understand

the relation between Epo, TNF-alpha and Quercetin.

Quercetin may be a source of treatment for anemia in chronic

inflammatory diseases, as well as many other known effects.